SEC Form 4 · accession 0001562180-15-000620
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Kanes
Officer — Chief Medical Officer
Period of report
Jul 27, 2015
Accepted (ET)
Jul 29, 2015 · 1:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2015 | M | 1,936 | $0.45 | A | 48,884 | D | |
| Common StockF1 | Jul 27, 2015 | S | 500 | $72.00 | D | 48,384 | D | |
| Common StockF1,F2 | Jul 27, 2015 | S | 800 | $69.38 | D | 47,584 | D | |
| Common StockF1,F3 | Jul 27, 2015 | S | 636 | $68.50 | D | 46,948 | D | |
| Common StockF1,F4 | Jul 27, 2015 | S | 220 | $73.64 | D | 46,728 | D | |
| Common StockF1,F5 | Jul 27, 2015 | S | 826 | $72.08 | D | 45,902 | D | |
| Common StockF1,F6 | Jul 27, 2015 | S | 400 | $70.91 | D | 45,502 | D | |
| Common StockF1,F7 | Jul 27, 2015 | S | 900 | $69.60 | D | 44,602 | D | |
| Common StockF1,F8 | Jul 27, 2015 | S | 654 | $68.67 | D | 43,948 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F9 | $0.45 | Jul 27, 2015 | M | 1,936 | D | — | Jul 23, 2023 | Common Stock | 1,936 | 154,100 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $68.86 USD to $69.85 USD. The price reported above reflects the weighted average sale price.
- F3This transaction was executed in multiple trades at prices ranging from $68.23 USD to $68.77 USD. The price reported above reflects the weighted average sale price.
- F4This transaction was executed in multiple trades at prices ranging from $73.22 USD to $73.715 USD. The price reported above reflects the weighted average sale price.
- F5This transaction was executed in multiple trades at prices ranging from $72.00 USD to $72.34 USD. The price reported above reflects the weighted average sale price.
- F6This transaction was executed in multiple trades at prices ranging from $70.30 USD to $71.19 USD. The price reported above reflects the weighted average sale price.
- F7This transaction was executed in multiple trades at prices ranging from $69.01 USD to $70.01 USD. The price reported above reflects the weighted average sale price.
- F8This transaction was executed in multiple trades at prices ranging from $68.34 USD to $68.92 USD. The price reported above reflects the weighted average sale price.
- F925% of this option vested on July 18, 2014, and the remainder vests in equal monthly installments thereafter over 36 months.